Circulation. 2004;109:2046-2049
Published online before print April 19, 2004, doi: 10.1161/01.CIR.0000127953.98131.ED
Published online before print April 19, 2004, doi: 10.1161/01.CIR.0000127953.98131.ED
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:2046-2049.)
© 2004 American Heart Association, Inc.
Brief Rapid Communications |
Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages
From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University (M.K., S.K., N.O., H.K., Y.O., K.O., K.M., H.N., K.K., N.M., A.N., T.F.), and Sumitomo Hospital (Y.M.), Osaka, Japan.
Correspondence to Shinji Kihara, MD, PhD, Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan. E-mail kihara{at}imed2.med.osaka-u.ac.jp
Received September 11, 2003; de novo received December 22, 2003; revision received March 23, 2004; accepted March 23, 2004.
Background— Vascular inflammation and subsequent matrix degradation play an important role in the development of atherosclerosis. We previously reported that adiponectin, an adipose-specific plasma protein, accumulated to the injured artery and attenuated vascular inflammatory response. Clinically, high plasma adiponectin level was associated with low cardiovascular event rate in patients with chronic renal failure. The present study was designed to elucidate the effects of adiponectin on matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in human monocyte-derived macrophages.
Methods and Results— Human monocyte-derived macrophages were incubated with the physiological concentrations of human recombinant adiponectin for the time indicated. Adiponectin treatment dose-dependently increased TIMP-1 mRNA levels without affecting MMP-9 mRNA levels. Adiponectin also augmented TIMP-1 secretion into the media, whereas MMP-9 secretion and activity were unchanged. Time course experiments indicated that TIMP-1 mRNA levels started to increase at 24 hours of adiponectin treatment and were significantly elevated at 48 hours. Adiponectin significantly increased interleukin-10 (IL-10) mRNA expression at the transcriptional level within 6 hours and significantly increased IL-10 protein secretion within 24 hours. Cotreatment of adiponectin with anti–IL-10 monoclonal antibody completely abolished adiponectin-induced TIMP-1 mRNA expression.
Conclusions— Adiponectin selectively increased TIMP-1 expression in human monocyte-derived macrophages through IL-10 induction. This study identified, for the first time, the adiponectin/IL-10 interaction against vascular inflammation.
Key Words: proteins • glycoproteins • metalloproteinases • interleukins • inflammation
This article has been cited by other articles:
 |
|
 |
|
  E. Th. Petridou, T. N. Sergentanis, N. Dessypris, I. T. Vlachantoni, S. Tseleni-Balafouta, A. Pourtsidis, M. Moschovi, S. Polychronopoulou, F. Athanasiadou-Piperopoulou, M. Kalmanti, et al. Serum Adiponectin As a Predictor of Childhood Non-Hodgkin's Lymphoma: A Nationwide Case-Control Study J. Clin. Oncol., October 20, 2009; 27(30): 5049 - 5055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Folco, V. Z. Rocha, M. Lopez-Ilasaca, and P. Libby Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10 J. Biol. Chem., September 18, 2009; 284(38): 25569 - 25575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Heymans, E. Hirsch, S. D. Anker, P. Aukrust, J.-L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, February 1, 2009; 11(2): 119 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Claudino, A. P. F. Trombone, C. R. Cardoso, S. B. Ferreira Jr, W. Martins Jr, G. F. Assis, C. F. Santos, P. C. Trevilatto, A. P. Campanelli, J. S. Silva, et al. The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome J. Leukoc. Biol., December 1, 2008; 84(6): 1565 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Sood, X Cui, C Qualls, W S Beckett, M D Gross, M W Steffes, L J Smith, and D R Jacobs Jr Association between asthma and serum adiponectin concentration in women Thorax, October 1, 2008; 63(10): 877 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Zyromski, A. Mathur, H. A. Pitt, D. Lu, J. T. Gripe, J. J. Walker, K. Yancey, T. E. Wade, and D. A. Swartz-Basile A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G552 - G558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pini, M. E. Gove, J. A. Sennello, J. W. P. M. van Baal, L. Chan, and G. Fantuzzi Role and Regulation of Adipokines during Zymosan-Induced Peritoneal Inflammation in Mice Endocrinology, August 1, 2008; 149(8): 4080 - 4085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-h. Park, H. Huang, M. R. McMullen, K. Bryan, and L. E. Nagy Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in raw 264.7 macrophages J. Leukoc. Biol., May 1, 2008; 83(5): 1258 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schnoor, P. Cullen, J. Lorkowski, K. Stolle, H. Robenek, D. Troyer, J. Rauterberg, and S. Lorkowski Production of Type VI Collagen by Human Macrophages: A New Dimension in Macrophage Functional Heterogeneity J. Immunol., April 15, 2008; 180(8): 5707 - 5719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakagawa, K. Kishida, S. Kihara, M. Sonoda, A. Hirata, A. Yasui, H. Nishizawa, T. Nakamura, R. Yoshida, I. Shimomura, et al. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E778 - E784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Okamoto, E. J. Folco, M. Minami, A.K. Wara, M. W. Feinberg, G. K. Sukhova, R. A. Colvin, S. Kihara, T. Funahashi, A. D. Luster, et al. Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis Circ. Res., February 1, 2008; 102(2): 218 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations Proceedings of the ATS, December 1, 2007; 4(8): 626 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L'Abbate, D. Neglia, C. Vecoli, M. Novelli, V. Ottaviano, S. Baldi, R. Barsacchi, A. Paolicchi, P. Masiello, G. S. Drummond, et al. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3532 - H3541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ohashi, H. Iwatani, S. Kihara, Y. Nakagawa, N. Komura, K. Fujita, N. Maeda, M. Nishida, F. Katsube, I. Shimomura, et al. Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1910 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Thalmann and C. A. Meier Local adipose tissue depots as cardiovascular risk factors Cardiovasc Res, September 1, 2007; 75(4): 690 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Katagiri, T. Yamada, and Y. Oka Adiposity and Cardiovascular Disorders: Disturbance of the Regulatory System Consisting of Humoral and Neuronal Signals Circ. Res., July 6, 2007; 101(1): 27 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Musaad and E. N. Haynes Biomarkers of Obesity and Subsequent Cardiovascular Events Epidemiol. Rev., May 10, 2007; (2007) mxm005v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hosogai, A. Fukuhara, K. Oshima, Y. Miyata, S. Tanaka, K. Segawa, S. Furukawa, Y. Tochino, R. Komuro, M. Matsuda, et al. Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation Diabetes, April 1, 2007; 56(4): 901 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Szmitko, H. Teoh, D. J. Stewart, and S. Verma Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1655 - H1663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Hopkins, N. Ouchi, R. Shibata, and K. Walsh Adiponectin actions in the cardiovascular system Cardiovasc Res, April 1, 2007; 74(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lucotti, E. Setola, L. D. Monti, E. Galluccio, S. Costa, E. P. Sandoli, I. Fermo, G. Rabaiotti, R. Gatti, and P. Piatti Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E906 - E912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cavusoglu, C. Ruwende, V. Chopra, S. Yanamadala, C. Eng, L. T. Clark, D. J. Pinsky, and J. D. Marmur Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain Eur. Heart J., October 1, 2006; 27(19): 2300 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Otsuka, S. Sugiyama, S. Kojima, H. Maruyoshi, T. Funahashi, K. Matsui, T. Sakamoto, M. Yoshimura, K. Kimura, S. Umemura, et al. Plasma Adiponectin Levels Are Associated With Coronary Lesion Complexity in Men With Coronary Artery Disease J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1155 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vachharajani and S. Vital Obesity and Sepsis J Intensive Care Med, September 1, 2006; 21(5): 287 - 295. [Abstract] [PDF]
|
|
|
|
|
|
K.-y. Kim, J. K. Kim, S. H. Han, J.-S. Lim, K. I. Kim, D. H. Cho, M.-S. Lee, J.-H. Lee, D.-Y. Yoon, S. R. Yoon, et al. Adiponectin Is a Negative Regulator of NK Cell Cytotoxicity J. Immunol., May 15, 2006; 176(10): 5958 - 5964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Neumeier, J. Weigert, A. Schaffler, G. Wehrwein, U. Muller-Ladner, J. Scholmerich, C. Wrede, and C. Buechler Different effects of adiponectin isoforms in human monocytic cells J. Leukoc. Biol., April 1, 2006; 79(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Manigrasso, P. Ferroni, F. Santilli, T. Taraborelli, M. T. Guagnano, N. Michetti, and G. Davi Association between Circulating Adiponectin and Interleukin-10 Levels in Android Obesity: Effects of Weight Loss J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5876 - 5879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis J. Lipid Res., September 1, 2005; 46(9): 1812 - 1822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hamerman Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies QJM, July 1, 2005; 98(7): 467 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Yamamoto, T Kiyohara, Y Murayama, S Kihara, Y Okamoto, T Funahashi, T Ito, R Nezu, S Tsutsui, J-I Miyagawa, et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease Gut, June 1, 2005; 54(6): 789 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Berg and P. E. Scherer Adipose Tissue, Inflammation, and Cardiovascular Disease Circ. Res., May 13, 2005; 96(9): 939 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kadowaki and T. Yamauchi Adiponectin and Adiponectin Receptors Endocr. Rev., May 1, 2005; 26(3): 439 - 451. [Abstract] [Full Text] [PDF]
|
|